Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05828121
Other study ID # POINTstavanger
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 1, 2022
Est. completion date June 1, 2025

Study information

Verified date April 2023
Source Helse Stavanger HF
Contact Kine Gjesdal, PhD
Phone 004748136702
Email kine.gjesdal@sus.no
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators do research on chronic pain treatment to minimize the risks associated with opioids.


Description:

The investigators know that patients suffering from chronic pain need good treatment. The use of opioids for chronic, non-cancer related pain may seem appropriate in the short term, but can often have negative consequences for both the individual and society in the long term. Several factors-the escalating use of opioids to chronic pain patients, the increasing use of strong opioids in particular, and the increasing number of overdoses caused by prescription opioids-point to the start of an opioid epidemic in Norway. Objectives The overall goal of the POINT project is to provide knowledge to optimize treatment of patients with chronic pain in order to avoid unnecessary escalation of opioid treatment, improve their quality of life and reduce the burden of disease. In the long run our objective is to prevent the unwanted consequences of opioid treatment and improve patients' quality of life. Ultimately, through this project the investigators hope to prevent an opioid epidemic in Norway. To achieve the main goal, the investigators will focus on pain patients and their doctors, as increasing opioid use may occur through the patient-doctor interaction. Methods The project will develop and test a non-drug interventions that consist of an interdisciplinary group treatment . Financing The Research Council of Norway Cooperation St. Olavs Hospital Stavanger Hospital Trust City of Stavanger National Institute of Public Health (FHI) Alcohol and Drug Research Western Norway (KoRFor) Foreningen for kroniske smertepasienter (FKS) Norwegian Forum of Disabled Peoples' Organizations (SAFO) Cooperation with other projects Injury Prevention and Outcomes following Trauma


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date June 1, 2025
Est. primary completion date June 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 67 Years
Eligibility Inclusion Criteria: - non-malignant, chronic pain - Registered in Stavanger municipality - Consent to participation. - Age 18 - 67 years - Pain duration <10 years Exclusion Criteria: - malignant pain condition

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
POINT1
Receiving treatment

Locations

Country Name City State
Norway Stavanger municipality Stavanger

Sponsors (2)

Lead Sponsor Collaborator
Helse Stavanger HF The Research Council of Norway

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change From Baseline in Audit C at 12 Weeks Audit C 12 weeks
Primary Change from baseline in Pain Scores on the Visual Analog Scale at 12 Weeks Visual Analog Scale 12 weeks
Primary Change from baseline in Bergen Insomnia scale at 12 Weeks BIS 12 weeks
Primary Change from baseline in Health-related quality of life at 12 Weeks HQ5D5L 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain